✦ LIBER ✦

A phase I trial of PKC412, an inhibitor of protein kinase C, in combination with bolus 5-Fluorouracil and leucovorin in patients with stage IV colorectal cancer

✍ Scribed by K. Weigang-Köhler; H. Bouterfa; U. Bruntsch; J. Buekki; C. Dutreix; G. Greim; M. Heike; C. Peschel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An EORTC phase I study of Bortezomib in

✍ F. Caponigro; D. Lacombe; C. Twelves; J. Bauer; A.-S. Govaerts; S. Marréaud; A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 214 KB

A Phase II trial of weekly infusional 5-

✍ Naomi B. Haas; Russell J. Schilder; Sherry Nash; Louis M. Weiner; Robert C. Cata 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 444 KB

A phase II trial of gefitinib with 5-flu

✍ Veronese, M L; Sun, W; Giantonio, B; Berlin, J; Shults, J; Davis, L; Haller, D G 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 79 KB

A phase I study of 5-fluorouracil, leuco

✍ Charles D. Blanke; Nora C. Mattek; Thomas G. Deloughery; Dennis R. Koop 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Phase I study of PKC412, a protein kinas

✍ Monnerat, C; Henriksson, R; Raymond, E; Berthaud, P; Vicente-Azevedo, J; Laveniu 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Phase I study of gefitinib, irinotecan,

✍ Jeffrey A. Meyerhardt; Jeffrey W. Clark; Jeffrey G. Supko; Joseph P. Eder; Shuji 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 329 KB